Boston Scientific details global disruption after cybersecurity incident

On Tuesday, Boston Scientific Corporation (NYSE: BSX ) identified a cybersecurity incident on Tuesday that caused global operational disruptions, including delays in processing and shipping customer orders.

The company activated its incident response plan and hired third-party cybersecurity experts to contain the threat.

In a Wednesday SEC filing, the medical device maker noted that system access remains limited and the timeline for full restoration is currently unknown.

Read Also: iRhythm Investigates Cyber Incident After Hackers Claim Access To Sensitive Data Boston Scientific Says Scope And Financial Impact Remain Unclear The company’s investigation of the cybersecurity incident is ongoing, and the full scope, nature, and impacts, including operational and financial impacts, of the incident are not yet known.

Accordingly, the company has not yet determined whether the incident is reasonably likely to have a material impact on the company.

Boston Scientific cut its fiscal 2026 outlook, citing pressures on the Watchman and EP markets.

The medical technology giant reported revenues of $5.442 billion on Wednesday, better than the consensus estimate of $5.361 billion, beating the management guidance of $5.34 billion-$5.44 billion.

In June, Novo Nordisk A/S (NYSE: NVO ) said it is investigating claims by cyber extortion group FulcrumSec, which alleges it stole more than a terabyte of data from the pharmaceutical company and is considering selling portions of the information after an unsuccessful $25 million ransom demand.

BSX Stock Price Activity: Boston Scientific shares were down 4.32% at $47.70 at the time of publication on Wednesday, according to Pro data.

Read Also: Williams-Sonoma Says Outlook Hike Is Operational—Not Fueled By Tariff Refund Image via Shutterstock